According to a review of existing research published last month, the compounds found in cannabis could provide a new source of antibiotics, but further research is needed to find their full potential in fighting pathogens.
Many producers believe that these changes could be setting the stage for a future crackdown on the market.
Carried out by the Californian branch of SC Labs, the investigation also found detectable amounts of pesticides in 16 percent of the samples, and five percent registered over the allowable action limits.
The researchers hope that, by giving patients CBD and monitoring their brains, they can one day develop targeted treatment options for the spinal condition.
In their new study, published in Addiction, the researchers compared data from adolescent siblings to determine the potential impact of early or frequent cannabis use on cognitive function.
Under close review, analysts found that significantly more funding was given to research into the negative effects of cannabis and cannabis misuse than on its medical and therapeutic uses.
A new study of 21 American CBD products, currently in preprint, has found evidence that many products are mislabeled, contaminated, and deliberately adulterated.
While the cannabis-consuming patients were on average 15 years younger than the other patients - a factor that could help them recover from injuries at a faster rate - the study’s authors still say THC could have afforded some protective effect.